| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 68,360 | 66,042 | 73,246 | 65,329 | | Cost of Revenue | 54,195 | 50,638 | 54,696 | 53,057 | | | Gross Profit | 14,165 | 15,404 | 18,550 | 12,272 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,511 | 7,596 | 7,754 | 6,566 | | Non Recurring | (2) | 7 | (56) | 241 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,656 | 7,801 | 10,852 | 5,465 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | 23 | 7 | 44 | | Earnings Before Interest And Taxes | 6,689 | 7,824 | 10,859 | 5,509 | | Interest Expense | (42) | (47) | 89 | 404 | | Income Before Tax | 6,731 | 7,871 | 10,770 | 5,105 | | Income Tax Expense | 143 | 135 | 151 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,588 | 7,736 | 10,619 | 5,105 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,588 | 7,736 | 10,619 | 5,105 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,588 | $7,736 | $10,619 | $5,105 |
|
0.01% Nasdaq 0.00%
Income Statement
